the only duck quacking is Joko and he works for Affleck. Do you honestly believe 1-2 years more to seriously decide if GERN's a winner or not? WRT to all three on going current trials two of which are phase 2(IMBark NCT02426086 & MF NCT01731951) and one well into phase 3 (Emerge, NCT02598661) not mention all the 6 years of data already collected on IMET me thinks our capricious CEO is bagging our timelines for some other nefarious cause.
the deal he cut with Janssen has yet to gain traction. We are at the same SP pretty well as when the deal was announced in 2014 despite all the spin. SP day after the announcement Nov 14. $2.71 gradually moving up to $3.84 on Nov 24 before dropping back down. We are currently at $ 3.20 with almost 2 years of straight positive news. Tell me again no one rigs this market. And why did Chippy move fwd with the shelf registration when he really didn't need the funds from the dilution in 2014? His reckless actions wrt shareholder value is the number one reason the SP is in the doldrums. The INCY lobby excuse no longer holds much merit so the spin doctors from corporate need to find another boogeyman to chase.
IMerge is already classed as a phase 2/3 study. Shorter time frame than 18 months expected for transition for phase 3 completion.
now if we could only get the rate of civic political literacy above 2% we might have hope for economic prosperity and the quality of life. I'm a creationist who builds dams
he could have kept his trap shut all of last year on an acquisition dilution deal he was cooking...had it not been for that we'd be at least $2 higher right now.
so why isn't this a "news " item?
option put buys seem to take precedence.
personally I don't enjoy what little gains (13%) GERN made last month get clawed all back by this big foot hedge fund monster
Chippy doesn't go out drinking alone after these conference call presentations. It's to discuss no doubt strategy on SP manipulation
GERN's new boogyman's a monster
"option MONSTER's tracking program detected the purchase of 2,000 September 2.50 puts for $0.20 at the same time yesterday. This represents fresh buying, as open interest in the strike was only 200 contracts before the trade occurred.Long puts lock in the price where a stock can be sold, so they make money to the downside. Investors use them to hedge long positions or to speculate on a drop.
GERN fell 0.62 percent to $3.22 yesterday but is up 13 percent in the last month. The bio pharmaceutical company's next quarterly results are estimated for release after the close on April 28." and the way Chippy's been spending we can all predict earnings results.
speaking of other stocks Lumber Lar, what is your next CPXX pick? Thanx in advance.
Joko and his hedge fund's new short term goal target is back again folks. Watch the show...it's a day time regular starting at 9:30 am ;"The churn in GERN" starring Chippy as the wild & absent Hugh Hefner playboy CEO, and Dr. T as the pauper underdog superhero who spills the beans on corporate every once in a while. Other stars such as Irish the trader with her 4 leaf clover guest star John the leprechaun (no one has seen him yet but he promises a pot o gold to each investor) They are all kept together with a big roll of J&J bandage tape.
Stay tuned with Annie as we wait for the next 2 episodes in "The Churn in GERN"
" full FDA approval should have happened "yesterday" and may happen "tomorrow". ODD status is here now." then why have they not applied for BAT under expedited approval? that would still take 2 years.
Mangy so let me get this right ;Dr.T. is allowed to discuss data from the IMBark study which is owned and run exclusively by Janssen, yet our CEO is hiding behind the veil of PR silence claiming Janssen will not allow any company PR on these trials data until they deem fit? Who is lying I'd like to know?